The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients

Yalcin, Serap; MUTLU, PELİN; Cetin, Turker; Sarper, Meral; Ozgur, Gokhan; Avcu, Ferit

doi:10.4274/tjh.2014.0126

The-137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients

Atıf İçin Kopyala

Yalcin S., MUTLU P. , Cetin T., Sarper M., Ozgur G., Avcu F.

TURKISH JOURNAL OF HEMATOLOGY, cilt.32, sa.4, ss.311-316, 2015 (SCI İndekslerine Giren Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Konu: 4
Basım Tarihi: 2015
Doi Numarası: 10.4274/tjh.2014.0126
Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
Sayfa Sayıları: ss.311-316

Özet

Objective: Interleuldn-18 (IL-18) is a cytokine that belongs to the IL-1 superfamily and is secreted by various immune and nonimmune cells. Evidence has shown that 1L-18 has both anticancer and procancer effects. The aim of this study was to evaluate the relationship between IL-18 gene polymorphisms and susceptibility to chronic lymphocytic leukemias (CLL) and chronic myelogenous leukemias (CML) in Turkish patients.